Skip to content

Medi-Ject Corp.

United StatesFDA applicant, unverified

Devices
3

What Medi-Ject Corp. makes

Medi-Ject Corp. manufactures needle-free insulin delivery systems, including the Medi-Jector Choice and modifications for precise subcutaneous insulin administration. Their portfolio also includes needle-free drug delivery systems, such as the Medi-Jector Bio-Tropin DDRUG system with specific nozzle orifice diameters for targeted medication delivery.

These devices are classified under Class II by the FDA and are listed under the 510(k) regulatory pathway. Medi-Ject Corp. is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue3

Newest first, rows 1-3 of 3

Frequently asked questions

How many devices does Medi-Ject Corp. have in the registry?

The registry currently lists 3 devices for Medi-Ject Corp.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Medi-Ject Corp.'s devices?

Among its 3 most recently registered devices, Medi-Ject Corp. has devices listed in FDA 510(k) (3 devices).

What risk classes do Medi-Ject Corp.'s devices fall under?

Among its 3 most recently registered devices, the classes recorded for Medi-Ject Corp.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Medi-Ject Corp. in the registry?

The most recently registered devices listed for Medi-Ject Corp. include MEDI-JECTOR CHOICE NEEDLE-FREE INSULIN DELIVERY SYSTEM, MEDI-JECT CORPORATION MEDI-JECTOR NEEDLE-FREE BIO-TROPIN DDRUG DELIVERY SYSTEMS 0.0058/0.0068(INCH DIAMETER NOZZLEORIFIC and MODIFICATION TO MEDI-JECT CORPORATION MEDI-JECTOR CHOICE NEEDLE-FREE INSULIN DELIVERY SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.